Can I read CHANCE vs POINT Trial Summary on EtoBox?
CHANCE vs POINT Trial Summary by nurdiansyah is a document available to read on EtoBox.
What is CHANCE vs POINT Trial Summary about?
The CHANCE trial and POINT trial compared dual antiplatelet therapy of clopidogrel and aspirin to aspirin alone for secondary stroke prevention in patients with recent transient ischemic attack or minor ischemic stroke. Both trials found that dual antiplatelet therapy significantly reduced the risk of recurrent stroke within 90 days compared to aspirin alone, but the POINT trial also found a higher risk of major hemorrhage with dual therapy. The trials demonstrated that clopidogrel plus aspirin provides add
- Author
- nurdiansyah
- Language
- EN